Equities researchers at William Blair raised their FY2024 EPS estimates for shares of Moderna in a research report issued to ...
William Blair has upgraded CVRx (NASDAQ:CVRX) to outperform from market perform, citing utilization improvements and ...
Stock Trading Recap. On Friday, Tenaya Therapeutics Inc (TNYA) stock saw a modest uptick, ending the day at $1.4 which represents a slight increase ...
Equities research analysts at William Blair cut their FY2024 earnings per share estimates for shares of MarketAxess in a ...
William Blair International Growth Fund earns an Average Process Pillar rating. The most important driver of the rating is the stability of the management team. Specifically, the fund has not seen ...
Procept Biorobotics Corp (PRCT) stock saw a decline, ending the day at $76.02 which represents a decrease of $-2.82 or -3.58% from the prior close of $78.84. The stock opened at $79.26 and touched a ...
Neumora Therapeutics’ phase 3 fail was worse than analysts feared. | Neumora Therapeutics’ phase 3 fail was worse than ...
For investors looking for opportunities in fintech, SoFi presents an interesting case. Here's where analysts think the stock ...
William Blair analyst Andrew Jeffrey initiated coverage of SoFi Technologies (SOFI) with an Outperform rating and no price target The firm ...
William Blair reaffirmed their outperform rating on shares of Denali Therapeutics (NASDAQ:DNLI – Free Report) in a report ...